Pharmaceutical foreign trade situation throughout last year, Xu Ming believes that global pharmaceutical economy remain "weak growth" patterns, economic recovery in developed countries and more, slowing economic growth in developing countries, international market demand continues to be weak, domestic pharmaceutical industry entered a period of transition, existing comparative advantages are lost, but new impetus to spur trade growth has yet to emerge.
On February 10, reporters from 2014 medicine Conference was informed that the international trade situation in 2013, China's medicine and health products import and export volume reached US $ 89.693 billion, an increase of 10.27%. Among them, 51.18 billion US dollars, an increase of 6.84%, imported 38.513 billion dollars, an increase of 15.17%, 12.666 billion US dollars of foreign trade, fell by more than 12%.
"In the coming year, pharmaceutical import and export increase is expected to remain at around 10%, in 2014, China's pharmaceutical import and export volume to the billions of dollars mark in advance. "Chinese medicine and health products import and export Chamber of Commerce Vice President Xu Ming said.
Next: No Information